Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-09-09, Stock:JNJ, The news for the past five days is as follows:
2019-08-30: NEWS1: It’s Time to Short Johnson & Johnson Stock.NEWS2: It’s Time to Short Johnson & Johnson Stock.NEWS3: Dow Jones Rallies On China Trade Hopes; J&J Opioid Ruling, Best Buy, Burlington Stores, Ulta Beauty Earnings: Weekly Review.NEWS4: How the Johnson & Johnson Ruling Could Affect the Opioid Cases.NEWS5: It’s Time to Short Johnson & Johnson Stock.NEWS6: Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs.NEWS7: Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs.NEWS8: AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails.NEWS9: 3 Large-Cap Stocks to Sell in September.NEWS10: Purdue eyeing $12 billion settlement for 2,000 lawsuits.NEWS11: AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails.NEWS12: Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs.NEWS13: Will Opioid Litigation Take its Toll on Pharma Companies?.NEWS14: Will Opioid Litigation Take its Toll on Pharma Companies?.NEWS15: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 03, 2019.NEWS16: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 03, 2019.NEWS17: Will Opioid Litigation Take its Toll on Pharma Companies?.NEWS18: Litigation alone cannot heal the opioid epidemic.NEWS19: A selection of the FT’s biggest stories and best reads every Friday.NEWS20: Papa John's Is Ready for Its Turnaround.NEWS21: Papa John's Is Ready for Its Turnaround.
2019-09-03: NEWS1: What the Johnson & Johnson Opioid Ruling Means for the Cannabis Industry.NEWS2: What the Johnson & Johnson Opioid Ruling Means for the Cannabis Industry.NEWS3: What the Johnson & Johnson Opioid Ruling Means for the Cannabis Industry.NEWS4: UPDATE 1-U.S. judge orders big drug companies to face opioid trial.NEWS5: iShares Russell 3000 ETF Experiences Big Inflow.NEWS6: iShares Russell 3000 ETF Experiences Big Inflow.NEWS7: The Zacks Analyst Blog Highlights: J&J, Eli Lilly, Bristol-Myers, Roche and AbbVie.NEWS8: The Zacks Analyst Blog Highlights: J&J, Eli Lilly, Bristol-Myers, Roche and AbbVie.NEWS9: Can Roche's Blockbuster Drug Herceptin's Sales Grow?.NEWS10: Can Roche's Blockbuster Drug Herceptin's Sales Grow?.NEWS11: Health Care Sector Update for 09/03/2019: CDTX, ENDP, MRK, ARDS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 09/03/2019: CDTX, ENDP, MRK, ARDS, JNJ, PFE, ABT, MRK, AMGN.NEWS13: The Zacks Analyst Blog Highlights: J&J, Eli Lilly, Bristol-Myers, Roche and AbbVie.NEWS14: Bayer hires former J&J executive for more pharma deals.
2019-09-04: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Health Care Sector Update for 09/04/2019: OPGN, PBYI, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 09/04/2019: OPGN, PBYI, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Forget Coca-Cola: Here Are 2 Better Dividend Stocks.
2019-09-05: NEWS1: How Will Johnson & Johnson&apos;s Opioid Case Ruling Impact Big Pharma Stocks?.NEWS2: Mallinckrodt’s plunges toward record low after report bankruptcy is being considered.NEWS3: Mallinckrodt’s stock suffers record plunge after report bankruptcy is being considered.NEWS4: Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?.NEWS5: Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?.NEWS6: J&J's Stelara Gets Approval in EU for Ulcerative Colitis.NEWS7: J&J's Stelara Gets Approval in EU for Ulcerative Colitis.NEWS8: 4 Classic Defensive Dividend Stocks for Steady Returns.NEWS9: 4 Classic Defensive Dividend Stocks for Steady Returns.NEWS10: Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease.NEWS11: J&J's Stelara Gets Approval in EU for Ulcerative Colitis.NEWS12: Health Care Sector Update for 09/05/2019: MNK, ZFGN, LVGO, JNJ, PFE, MRK, ABT, AMGN.NEWS13: Health Care Sector Update for 09/05/2019: MNK, ZFGN, LVGO, JNJ, PFE, MRK, ABT, AMGN.NEWS14: [video]Johnson & Johnson Is Especially Attractive in Today's Low-Rate Environment.NEWS15: Johnson & Johnson Is A Massive Pharma Stock — But Should You Buy It?.NEWS16: 4 Defensive Dividend Stocks for Steady Returns.NEWS17: [video]Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy.NEWS18: How Important Is Keytruda For Merck?.NEWS19: How Important Is Keytruda For Merck?.NEWS20: Can Biosimilars Be The Next Growth Driver For Pfizer?.NEWS21: Can Biosimilars Be The Next Growth Driver For Pfizer?.NEWS22: J&J: The next target of anger over America’s opioid crisis?.NEWS23: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS24: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS25: Large U.S. Stocks May Be Underestimating The Worldwide Manufacturing Recession.NEWS26: Large U.S. Stocks May Be Underestimating The Worldwide Manufacturing Recession.
2019-09-06: NEWS1: Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs.NEWS2: Health Care Sector Update for 09/06/2019: NTGN, MYOV, VIVE, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 09/06/2019: NTGN, MYOV, VIVE, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Mallinckrodt’s suffers record plunge after report bankruptcy is being considered.NEWS5: Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation.NEWS6: How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?.NEWS7: How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?.

Answer: Decrease